$24.97
arrow_drop_down1.38%Key Stats | |
---|---|
Open | $25.32 |
Prev. Close | $25.32 |
EPS | -5.30 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 25.06 | 25.89 |
52 Week Range | 13.57 | 53.08 |
Ratios | |
---|---|
EPS | -5.30 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Arvinas Appoints Andrew Saik as Chief Financial Officer and Treasurer
Cytek Biosciences (CTKB) Moves 5.1% Higher: Will This Strength Last?
Arvinas Announces Presentations for Two of its PROTAC® Investigational Programs Targeting BCL6 and LRRK2
Arvinas Announces Promotions of Ian Taylor, Ph.D. to President of Research and Development and Angela Cacace, Ph.D. to Chief Scientific Officer
Arvinas to Participate in Upcoming Investor Conferences
Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Congress